Scott D Larsen

ORCID

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 7

Top Venues

Journal of medicinal chemistry

ACS chemical neuroscience

ACS pharmacology & translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffery D Zwicker, David Smith, Alfredo J Guerra, Jacob R Hitchens, Nicole Haug, Steve Vander Roest, Pil Lee, Bo Wen, Duxin Sun, Lu Wang, Richard F Keep, Jianming Xiang, Vern B Carruthers, Scott D Larsen
Discovery and Optimization of Triazine Nitrile Inhibitors of Toxoplasma gondii Cathepsin L for the Potential Treatment of Chronic Toxoplasmosis in the CNS. ACS chemical neuroscience 11 (16) (2020)
Michael W Wilson, Liming Shu, Vania Hinkovska-Galcheva, Yafei Jin, Walajapet Rajeswaran, Akira Abe, Ting Zhao, Ruijuan Luo, Lu Wang, Bo Wen, Benjamin Liou, Venette Fannin, Duxin Sun, Ying Sun, James A Shayman, Scott D Larsen
Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3. ACS chemical neuroscience 11 (20) (2020)
Erika M Lisabeth, Dylan Kahl, Indiwari Gopallawa, Sarah E Haynes, Sean A Misek, Phillip L Campbell, Thomas S Dexheimer, Dinesh Khanna, David A Fox, Xiangshu Jin, Brent R Martin, Scott D Larsen, Richard R Neubig
Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Antifibrotic and Antimetastatic Compounds. ACS pharmacology & translational science 2 (2) (2019)
Dylan J Kahl, Kim M Hutchings, Erika Mathes Lisabeth, Andrew J Haak, Jeffrey R Leipprandt, Thomas Dexheimer, Dinesh Khanna, Pei-Suen Tsou, Phillip L Campbell, David A Fox, Bo Wen, Duxin Sun, Marc Bailie, Richard R Neubig, Scott D Larsen
5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma. Journal of medicinal chemistry 62 (9) (2019)
Helen V Waldschmidt, Kristoff T Homan, Marilyn C Cato, Osvaldo Cruz-Rodríguez, Alessandro Cannavo, Michael W Wilson, Jianliang Song, Joseph Y Cheung, Walter J Koch, John Joseph Grubb Tesmer, Scott D Larsen
Correction to "Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine". Journal of medicinal chemistry 62 (12) (2019)
Brandt C Huddle, Edward Grimley, Cameron D Buchman, Mikhail Chtcherbinine, Bikash Debnath, Pooja Mehta, Kun Yang, Cynthia A Morgan, Siwei Li, Jeremy Felton, Duxin Sun, Geeta Mehta, Nouri Neamati, Ronald J Buckanovich, Thomas D Hurley, Scott D Larsen
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. Journal of medicinal chemistry 61 (19) (2018)
Helen V Waldschmidt, Kristoff T Homan, Marilyn C Cato, Osvaldo Cruz-Rodríguez, Alessandro Cannavo, Michael W Wilson, Jianliang Song, Joseph Y Cheung, Walter J Koch, John J G Tesmer, Scott D Larsen
Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine. Journal of medicinal chemistry 60 (7) (2017)

Scott D Larsen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Scott D Larsen